Human ErbB2/Her2 (Research Grade Trastuzumab Biosimilar) Antibody, R&D Systems™

Human Monoclonal Antibody

Catalog Number	Mfr. No.	Quantity
MAB11042SP	R&D Systems MAB11042SP	25 μg
MAB11042100	R&D Systems MAB11042100	100 μg

Description

ErbB2/Her2 Monoclonal antibody specifically detects ErbB2/Her2 in Human samples. It is validated for Immunocytochemistry

Specifications

• Antigen: ErbB2/Her2
• Dilution: Immunocytochemistry 5-25 ug/mL
• Classification: Monoclonal
• Form: Purified
• Regulatory Status: RUO
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. Small pack size (SP) is supplied either lyophilized or as a 0.2 μm filtered solution in PBS.
• Gene ID (Entrez): 2064
• Isotype: IgG1
• Purification Method: Protein A or G purified from cell culture supernatant
• Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution.

• Clone: Hu4F2
• Applications: Immunocytochemistry
• Conjugate: Unconjugated
• Host Species: Human
• Target Species: Human
• Gene Alias: CD340, CD340 antigen, c-erb B2/neu protein, EC 2.7.10, EGFR2, HER2, HER-2, HER2EC 2.7.10.1, herstatin, Metastatic lymph node gene 19 protein, MLN 19, MLN19, Neu Oncogene, NEUHER-2/neu, neuroblastoma/glioblastoma derived oncogene homolog, NGL, NGLTKR1, p185erbB2, Proto-oncogene c-ErbB-2, Proto-oncogene Neu, receptor tyrosine-protein kinase erbB-2, TKR1, Tyrosine kinase-type cell surface receptor HER2, v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2(neuro/glioblastoma derived oncogene homolog), v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastomaderived oncogene homolog (avian)
• Immunogen: Human ErbB2/Her2,
• Primary or Secondary: Primary
• Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.